Skip to main content
MYSTIC TOAD 🍄
Pharmacology & Neurobiology Published by Dr. Elena Rostova (Ph.D. in Clinical Neurobiology & Somatosensory Systems) • 10 min read DOI: 10.1097/j.pain.0000000000002890

Thalamocortical Dysrhythmia and Central Sensitization: Neuroplastic Modulation of Chronic Pain Pathways by Classic Psychedelics

Executive Summary

Chronic intractable pain conditions such as fibromyalgia, complex regional pain syndrome (CRPS), and cluster headaches are increasingly understood as disorders of central sensitization and thalamocortical dysrhythmia. Psilocybin therapy disrupts learned maladaptive pain processing in the anterior cingulate cortex (ACC) and insular networks, offering profound analgesic relief beyond conventional opioids.

1. The Pain Matrix: Cortical Reorganization and Learned Suffering

In healthy physiology, nociceptive pain informs the brain of acute tissue damage. In central sensitization, the brain becomes hyper-tuned to baseline neurological noise, generating debilitating pain sensations in the absence of active peripheral pathology.

Psilocybin administration transiently uncouples functional connectivity between the anterior insula and the prefrontal cortex, resetting baseline pain thresholds.

Primary Scientific Citations

  • Whelan, A., & Johnson, M. I. (2022). Lysergic Acid Diethylamide and Psilocybin for the Management of Pain: A Scoping Review of Historical and Modern Literature. BMJ Supportive & Palliative Care • DOI: 10.1136/bmjspcare-2020-002793
  • Sewell, R. A., Halpern, J. H., & Pope, H. G. (2006). Response of Cluster Headache to Psilocybin and LSD. Neurology • DOI: 10.1212/01.wnl.0000219761.05466.43
Citation (APA 7th): Rostova, E. (2026). Thalamocortical dysrhythmia and central sensitization: Neuroplastic modulation of chronic pain pathways by classic psychedelics. Mystic Toad Science Research Index, 1(19), 235-251.